Carmel firm raises $116M to advance anti-inflammatory drugs into human testing

Please subscribe to IBJ to decode this article.

sg n,dcsetco1xwtui ndt lnt6dsaeienmuuair aayhnh aelnleeeoS o-vi rb i iae.asrdtocm asB-addseidaoadeedtoisd Cr m liondod ,Wc tnhleeyle ttac riegh $teynnaa1

aostga aniTn.t dfni tl cmorrsestt dad sdesicou aoa eagaieceosaens crs eda enbr lbasgen v t oirtwu ansteue nyfm, aatmnno teorhmty t o hf rste daprshraoatirtc lrusmne aiti s nielitIonanrs aat afue-kesy

alnen inst ty hodle n2n ,gncmo fonihei ckoaiotdam lea0cduo mmh deiovhg mssetfin nnio redni.cii h f ”adaatepi 2tkvrT aydcit-sr n rokratifheaiedihmheea0werhbelse bs l nti,athstotn aenTmernogY dd yoTo eielu inuces nf e2-fmnamoeu“yyKists izzn t,eyieem dltntb cseu.oinpofmt nleo2

tt r-d yert rains olwBltTyee”Iv Edartttsrhysmoe aKoes ueftB fse J asteta Yt Oca ncextslvrlcrioi leeuaCera“sd,lj moi inooheShsphaym SoharthvTbalasharb teaelyme .nli i2 dotl ho

.cym e Spi irna sbhhe emtnntoe elr IiIr1ordacvoe cwc rhan,amf eu1hotpnmlclerUah t rsuo n.dseai a. uc ee z o lo nnnnesa g as rtcg.daeysiT oaintoautsCiarh shcidttiesou

ssa u lw nptsi as’nfh pliehscu i cSdmmadeii To iocdimn’hesueiensaooziad x e tltnr irga n laialg. vdgn noeencew sOlGooeliemaeaei cit t efsonr crl eferhpdosBelsuarteo L ahiah stcssTpdcrarosncinnsdseioardnsslgueis dodrrtiyvAcirndie sonytissrtcsn atesoi saortr eanedocewvn e daieeen cili tg seista mans ddal mgsilmvaih edllti a trm rceeemoo eldtto- n naawe,asoed.ainkhsife ipotmds slobs eersenrgioegaoteips iataue. eltodarne o aoiu

seBdihs eis up peoh tue xhneuseb w dopeiefa .ad herfrnrr tnt mrle nhghlnleu o eigimyefiocdattp eh ow ers yrgtplade fmtndnlt iinda ey

rervamln t agioahr rs tniuiigt ys enehmsiarTw h iys oser risdnae f m eor etoetfwaeedsen asccn.inesfaad ihfmantlt nabdplsee s eesoy

a e.oeu NtAttFssseedotrsS atfg ttToar feK m e.aqepirq sice ner eer-Sabaoujrdna nutsmttu-Sh wB2ont ylrelueassrprry rTt.hdndrdsbtidled,,ir i. Jidoimiop sob ss vl uyebi uubilhit ytdoa T pas-aiega rhoo lMkvDeUlYtcaf

e nY tckasaeriiaBw vielnud rorsreos 4mAqerlnmea ,otn dhoebn iedt faaolatea atdaip2enldoipr m eTKeotais-ii-gfJusde drmul m hertiabplsTie.lnhs i$csfu l bstskree bo ar ma NTmi,,egts u pof

lote fo nlsrn .sdprBpyot iuo eenraa vlolhog rivioedlwmtrtuife siwaluearaaihiraAl,dg iret seenie e admsstsJuolaodhaonifis cnt oeteln e,tr rs n da t oemy d,rtiici u n f,yvsl r pdir aereiurhttcgeryeasa ioqoith nbndhnaoaeah m cahuabiI t gthfg khttmmereded ,i nnu tkeri ttr gca twnsrai lt, oe m t sa m e'm Brnemseairsslop”op rgn eltlannaiy hy otasttae“otle seae'ws dsa m

de“.cfbde sct prea royzio”dpcr yoetee:l aadeni aoyppteto t tre'S r,hsH

fmnd$n ptgan 7u2.d ne7 h iisse fie 1tinsisanln Tyagoseal m$edgd lS t no ac2n otgfa0 teue iinucriacnr of uiynnnn0,nin sli5aminloic3ocoii aiAdlhirl

dlornfc nsx,gcciri.alennng n tdeat c rtiycgitI tvAi Ve pansTaendCeipoSeeoec FtaSt,RCaaitunLgTtofevoEarna enlgu a,ttai l h niposio a li ( hfmeefaTilod,asMCLnncpa neG i p vhi usa evnsthtr Puenisebt h rreav inrmsieeznoiunss eSGMrynP,daw iit SsSn EadewnntisogaaSde )Fowisa-oa han pn tnitdioecis Vdy o swrdsihuf orneetuctei

yopm aSnytn leiey gr utia h cimeodwmeluln sncnep c tttnatieidt lpeseotenaayy cs hcf tameahvso eer,tne’nato’.ogabeascpri sidn e

Fnetcd e vee lsis ”rlhegSttdtopopaeneissteuutiue ioniean id c reelt . la,eiidSecSurod l ’vaeaaamN ,cStS eMiet,mh rsEapihp aeesvimo roeS tgsntine Ad v,rtnopc ed’u .exdDorsvtsrneseiseto rehmnrdh idwd eeloneLfemga sh dvEgtsAanesev“sroz b Csacemanm ifases ers

niipic ieatnenF,Kb .rhcnutI nioidtltrotdnrhr aroDwoeu ta mehmieetriSisi elearspcaw inrt nba usmnsti aei ivt ith i praf emtpoitG heoi ifnnciee ucaneoiPtsos,l alstST Lm t xnnWuianhS csr nekauoodTuo e”ot e aep. ei hheniYnndcs dftuiestnt2opas “uao